NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Receivables - Net (2014 - 2026)

NextPlat's (NXPL) quarterly Receivables - Net came in at $8.2 million in Q2 2026, up 159.0% year-over-year from $3.2 million in Q2 2025, and up 14.16% quarter-over-quarter from $7.2 million in Q1 2026.

Analysis

NextPlat (NXPL) Receivables - Net (2014 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Receivables - Net for 13 consecutive years, with $8.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Receivables - Net rose 159.0% year-over-year to $8.2 million in Q2 2026; TTM through Jun 2026 was $8.2 million, a 159.0% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 18.03% from the prior year.
  • Receivables - Net was $8.2 million for Q2 2026 at NextPlat, up from $7.2 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $12.9 million in Q1 2024 and troughed at $344915.0 in Q2 2022.
  • A 5-year average of $5.0 million and a median of $5.3 million in 2024 frame the typical range for Receivables - Net.
  • Across the five-year window, Receivables - Net soared 2294.53% in 2023 and sank 69.38% in 2025, its largest moves.
  • Over 5 years, Receivables - Net stood at $384000.0 in 2022, then soared by 2294.53% to $9.2 million in 2023, then slumped by 45.23% to $5.0 million in 2024, then climbed by 18.03% to $5.9 million in 2025, then jumped by 38.78% to $8.2 million in 2026.
  • The last three Receivables - Net figures came in at $8.2 million (Q2 2026), $7.2 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.25 Mn
Mar 31, 2026 7.23 Mn
Dec 31, 2025 5.94 Mn
Sep 30, 2025 4.07 Mn
Jun 30, 2025 3.19 Mn
Mar 31, 2025 5.59 Mn
Dec 31, 2024 5.04 Mn
Sep 30, 2024 6.60 Mn
Jun 30, 2024 10.40 Mn
Mar 31, 2024 12.93 Mn
Dec 31, 2023 9.20 Mn
Sep 30, 2023 7.80 Mn
Jun 30, 2023 600,000.00
Mar 31, 2023 1.00 Mn
Dec 31, 2022 384,000.00
Sep 30, 2022 700,000.00
Jun 30, 2022 344,915.00
Mar 31, 2022 420,143.00
Dec 31, 2021 349,836.00
Sep 30, 2021 309,839.00